-+ 0.00%
-+ 0.00%
-+ 0.00%

Mira Pharmaceuticals Begins Final Phase 1 Trial Cohort for Oral Ketamir-2 in Neuropathic Pain

Reuters·02/03/2026 12:30:57

Please log in to view news